Ask an Expert is a free question-and-answer service about breast cancer and breast health that is available on weekends. If you'd like to ask a question or comment, please visit us again on Saturday or Sunday. In the meantime, please search the existing topics using the search tool at the top of the page. It's quite possible that one of our many existing topics already addresses your question.
If you would like a consultation with a breast specialist at the Johns Hopkins Avon Foundation Breast Center, call 443-778-2778. It is possible to get an appointment for a second opinion within a few days of contacting us.
We hope you find the information helpful!
| Forum | Questions | Ask a Question | |
|---|---|---|---|
 |
LCIS - Lobular Carcinoma In Situ Questions about lobular carcinoma in situ. |
140 |  |
| Asked | Publicly Submitted Question | ||
|---|---|---|---|
| 1/26/2011 | Hi Lillie,What all factors are included in a high risk assessment of LCIS before a woman is prescribed an anti-estrogen? I was prescribed Evista because the results of my path report from surgery was LCIS. My surgery was a left breast needle LOC biopsy. I have reservations about taking Evista because of all the side effects. Are the results of my path report enough to start someone on an anti- estrogen pill? Do you have woman who refuse to take an anti-estrogen pill? What would you say to them about that when they refuse? Any input is appreciated. | ||
| Replied | JHU's Breast Center Reply | ||
| 1/26/2011 | To determine this requires a formal consultation with a high risk counselor who specializes in breast cancer genetics. family history, age at time of menstruation, age now, smoking history, alcohol use, HRT use, age at menopause (if that has happened yet), other medical conditions that are contraindicated for taking drugs like tamoxifen, and the list goes on and on. So having a woman's risk of breast cancer properly calculated is important before embarking on hormonal therapy for prevention. some women do opt to take medication and their only risk factor is LCIS; others opt not to and may even carry a breast cancer gene. | ||
Please note: This service is not intended to provide primary medical advice concerning specific medical care or treatment. Ask an Expert is a free service operated by health care professionals at the Johns Hopkins Avon Foundation Breast Center. Due to the volume of questions and their complexity, there are times when medical oncologists, surgeons, radiation oncologists or oncology nurses are consulted for their input. These individuals volunteer their time for this service and will respond as soon as they are able. Please do not post or send the same question to us in multiple locations or categories.